| Year |
Citation |
Score |
| 2023 |
Nikitas J, Ong WL, Carrier N, Romero T, Millar J, Steinberg ML, Rettig MB, Boutros PC, Reiter R, Nickols NG, Valle L, McGuire SE, Spratt DE, Souhami L, Roy S, et al. Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical Trials. International Journal of Radiation Oncology, Biology, Physics. PMID 38151191 DOI: 10.1016/j.ijrobp.2023.12.022 |
0.339 |
|
| 2020 |
Vantaku V, Putluri V, Bader DA, Maity S, Ma J, Arnold JM, Rajapakshe K, Donepudi SR, von Rundstedt FC, Devarakonda V, Dubrulle J, Karanam B, McGuire SE, Stossi F, Jain AK, et al. Correction: Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression. Oncogene. PMID 32820250 DOI: 10.1038/S41388-020-1283-7 |
0.571 |
|
| 2020 |
Boyce-Fappiano D, Bathala TK, Ye R, Pasalic D, Gjyshi O, Pezzi TA, Noticewala SS, McGinnis GJ, Maroongroge S, Kuban DA, Nguyen QN, McGuire SE, Hoffman KE, Choi S, Tang C, et al. Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy. Brachytherapy. PMID 32682778 DOI: 10.1016/J.Brachy.2020.06.011 |
0.37 |
|
| 2020 |
Abu-Gheida I, Bathala TK, Maldonado JA, Khan M, Anscher MS, Frank SJ, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Kim M, Kuban DA, Aparicio A, Chapin BF, Tang C. Increased frequency of Mesorectal and Perirectal LN involvement in T4 Prostate Cancers. International Journal of Radiation Oncology, Biology, Physics. PMID 32353391 DOI: 10.1016/J.Ijrobp.2020.04.025 |
0.423 |
|
| 2020 |
Bagley AF, Anscher MS, Choi S, Frank SJ, Hoffman KE, Kuban DA, McGuire SE, Nguyen QN, Chapin B, Aparicio A, Pezzi TA, Smith GL, Smith BD, Hess K, Tang C. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer. Jama Network Open. 3: e201255. PMID 32191331 DOI: 10.1001/jamanetworkopen.2020.1255 |
0.306 |
|
| 2020 |
Bader DA, McGuire SE. Tumour metabolism and its unique properties in prostate adenocarcinoma. Nature Reviews. Urology. PMID 32112053 DOI: 10.1038/S41585-020-0288-X |
0.646 |
|
| 2019 |
Lin C, Salzillo TC, Bader DA, Wilkenfeld SR, Awad D, Pulliam TL, Dutta P, Pudakalakatti S, Titus M, McGuire SE, Bhattacharya PK, Frigo DE. Prostate Cancer Energetics and Biosynthesis. Advances in Experimental Medicine and Biology. 1210: 185-237. PMID 31900911 DOI: 10.1007/978-3-030-32656-2_10 |
0.673 |
|
| 2019 |
Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Corn P, Logothetis C, Ward J, Frank SJ, Navai N, McGuire SE, et al. Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends. Cancer. PMID 31742674 DOI: 10.1002/Cncr.32570 |
0.431 |
|
| 2019 |
Vantaku V, Putluri V, Bader DA, Maity S, Ma J, Arnold JM, Rajapakshe K, Donepudi SR, von Rundstedt FC, Devarakonda V, Dubrulle J, Karanam B, McGuire SE, Stossi F, Jain AK, et al. Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression. Oncogene. PMID 31383940 DOI: 10.1038/S41388-019-0902-7 |
0.618 |
|
| 2019 |
Bader DA, Hartig SM, Putluri V, Foley C, Hamilton MP, Smith EA, Saha PK, Panigrahi A, Walker C, Zong L, Martini-Stoica H, Chen R, Rajapakshe K, Coarfa C, Sreekumar A, ... ... McGuire SE, et al. Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer. Nature Metabolism. 1: 70-85. PMID 31198906 DOI: 10.1038/s42255-018-0002-y |
0.623 |
|
| 2019 |
Fletcher CE, Sulpice E, Combe S, Shibakawa A, Leach DA, Hamilton MP, Chrysostomou SL, Sharp A, Welti J, Yuan W, Dart DA, Knight E, Ning J, Francis JC, Kounatidou EE, ... ... McGuire SE, et al. Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer. Oncogene. PMID 31043708 DOI: 10.1038/S41388-019-0823-5 |
0.326 |
|
| 2019 |
Pasalic D, Kuban DA, Allen PK, Tang C, Mesko SM, Grant SR, Augustyn AA, Frank SJ, Choi S, Hoffman KE, Nguyen QN, McGuire SE, Pollack A, Anscher MS. Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase III, Single Institution Randomized Clinical Trial. International Journal of Radiation Oncology, Biology, Physics. PMID 30836166 DOI: 10.1016/J.Ijrobp.2019.02.045 |
0.347 |
|
| 2019 |
Kalofonou F, Leach D, Hamilton M, Mcguire SE, Fletcher C, Waxman J, Bevan CL. MiR-1271-5p: An AR-modulatory microRNA with a distinct role in prostate cancer progression, through SND1 and MORF4L1 interaction. Journal of Clinical Oncology. 37: e16562-e16562. DOI: 10.1200/Jco.2019.37.15_Suppl.E16562 |
0.33 |
|
| 2019 |
Chapin BF, Wang X, Zhang M, Corn PG, Zurita AJ, Elsheshtawi MA, Davis JW, Pettaway CA, Adibi M, Gleave M, Cooperberg MR, Smaldone MC, Mcguire SE, Tu S, Wang J, et al. Complex biologic heterogeneity of de novo hormone naïve metastatic prostate cancer (HNPCa): Comparison of early progressors and prolonged responders to initial systemic treatment. Journal of Clinical Oncology. 37: 5055-5055. DOI: 10.1200/Jco.2019.37.15_Suppl.5055 |
0.337 |
|
| 2019 |
Aparicio A, Zhang M, Ramesh N, Wang X, Corn PG, Zurita AJ, Davis JW, Pettaway CA, Adibi M, Mcguire SE, Tu S, Wang J, Subudhi SK, Elsheshtawi MA, Efstathiou E, et al. Aggressive variant prostate cancer (AVPC) molecular signature in castration-sensitive, de novo metastatic prostate cancer (M1PCa). Journal of Clinical Oncology. 37: 5052-5052. DOI: 10.1200/Jco.2019.37.15_Suppl.5052 |
0.436 |
|
| 2019 |
Bagley A, Anscher M, Choi S, Frank SJ, Hoffman K, Kuban D, McGuire S, Nguyen Q, Smith B, Smith G, Pezzi TA, Chapin B, Aparicio A, Hess K, Tang C. Factors Affecting Receipt of Non-Definitive Therapy for High-Risk Prostate Cancer: A National Cancer Database Analysis International Journal of Radiation Oncology*Biology*Physics. 103: E13-E14. DOI: 10.1016/s0360-3016(19)30431-6 |
0.327 |
|
| 2019 |
Bagley A, Anscher M, Choi S, Frank S, Hoffman K, Kuban D, McGuire S, Nguyen Q, Smith B, Smith G, Chapin B, Aparicio A, Pezzi T, Hess K, Tang C. Factors Affecting Receipt of Non-Definitive Therapy for High-Risk Prostate Cancer: A National Cancer Database Analysis International Journal of Radiation Oncology*Biology*Physics. 105: E452. DOI: 10.1016/J.Ijrobp.2019.06.1498 |
0.434 |
|
| 2019 |
Hoffman K, Volk R, Chapin B, Tang C, Allen P, Anscher M, Choi S, Davis J, Frank S, McGuire S, Nguyen Q, Pettaway C, Kuban D. Impact of Multidisciplinary Counseling on Awareness of Prostate Cancer Treatment Options International Journal of Radiation Oncology*Biology*Physics. 105: E442. DOI: 10.1016/J.Ijrobp.2019.06.1476 |
0.428 |
|
| 2018 |
Hoffman KE, Voong KR, Levy LB, Allen PK, Choi S, Schlembach PJ, Lee AK, McGuire SE, Nguyen Q, Pugh TJ, Frank SJ, Kudchadker RJ, Du W, Kuban DA. Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018779868. PMID 30106637 DOI: 10.1200/Jco.2018.77.9868 |
0.436 |
|
| 2018 |
Koh EH, Chernis N, Saha PK, Xiao L, Bader DA, Zhu B, Rajapakshe K, Hamilton MP, Liu X, Perera D, Chen X, York B, Trauner M, Coarfa C, Bajaj M, ... ... McGuire SE, et al. miR-30a Remodels Subcutaneous Adipose Tissue Inflammation to Improve Insulin Sensitivity in Obesity. Diabetes. PMID 30002134 DOI: 10.2337/Db17-1378 |
0.575 |
|
| 2018 |
Moningi S, Kuban D, Allen P, Kanke J, Master P, Anscher M, Chapin B, Choi S, Chun S, Chronowski G, Delclos M, Garg A, Mayo L, McGuire S, Nguyen Q, et al. Prospective Cancer Control and Patient-reported Quality of Life after Post-prostatectomy Salvage Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e130-e131. DOI: 10.1016/J.Ijrobp.2018.07.347 |
0.43 |
|
| 2017 |
Frank SJ, Pugh TJ, Blanchard P, Mahmood U, Graber WJ, Kudchadker RJ, Davis JW, Kim J, Choi H, Troncoso P, Kuban DA, Choi S, McGuire S, Hoffman KE, Chen HC, et al. Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes. International Journal of Radiation Oncology, Biology, Physics. PMID 29229325 DOI: 10.1016/J.Ijrobp.2017.09.050 |
0.411 |
|
| 2017 |
Voong KR, Lal LS, Kuban DA, Pugh TJ, Swint JM, Godby J, Choi S, Lee AK, Schlembach PJ, Frank SJ, McGuire SE, Hoffman KE. Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial. Advances in Radiation Oncology. 2: 249-258. PMID 29114589 DOI: 10.1016/J.Adro.2017.07.010 |
0.359 |
|
| 2017 |
Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, et al. Quality of life following brachytherapy or bilateral nerve sparing robotic prostatectomy for prostate cancer: a prospective cohort. Bju International. PMID 28941030 DOI: 10.1111/Bju.14021 |
0.378 |
|
| 2017 |
Holliday EB, Kuban DA, Levy LB, Bolukbasi Y, Master P, Choi S, Nguyen Q, McGuire SE, Mahmood U, Frank SJ, Hoffman KE. Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy. Prostate Cancer and Prostatic Diseases. PMID 28462945 DOI: 10.1038/Pcan.2017.24 |
0.345 |
|
| 2017 |
Bader DA, Putluri N, Hartig SM, McGuire SE. Abstract 5431: Androgen receptor regulates the mitochondrial pyruvate carrier to fuel oncometabolism in prostate cancer Cancer Research. 77: 5431-5431. DOI: 10.1158/1538-7445.Am2017-5431 |
0.676 |
|
| 2016 |
Koh EH, Chen Y, Bader DA, Hamilton MP, He B, York B, Kajimura S, McGuire SE, Hartig SM. Mitochondrial activity in human white adipocytes is regulated by the Ubiquitin Carrier Protein 9/microRNA-30a axis. The Journal of Biological Chemistry. PMID 27758866 DOI: 10.1074/Jbc.M116.749408 |
0.587 |
|
| 2016 |
Hoffman KE, Voong KR, Levy LB, Pugh TJ, Choi S, Du W, Frank SJ, Johnson JL, Kudchadker R, Nguyen QN, Lee A, Mahmood U, McGuire SE, Kuban DA. Randomized Trial of Hypofractionated Dose-Escalated Intensity Modulated Radiation Therapy Versus Conventionally Fractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: S32. PMID 27675902 DOI: 10.1016/J.Ijrobp.2016.06.091 |
0.378 |
|
| 2016 |
Blanchard P, Davis JW, Frank SJ, Jeri K, Pettaway CA, Pugh TJ, Pisters LL, Mahmood U, Ward JF, Choi S, Chapin BF, Hoffman KE, Navai N, McGuire SE, Matin SF, et al. How to Counsel Patients With Localized Prostate Cancer About Treatment Selection: Quality-of-Life Results of a Prospective Single-Institution Cohort. International Journal of Radiation Oncology, Biology, Physics. 96: E534-E535. PMID 27674949 DOI: 10.1016/J.Ijrobp.2016.06.1967 |
0.394 |
|
| 2016 |
Frank SJ, Pugh TJ, Mahmood U, Blanchard P, Kudchadker R, Graber W, Kuban DA, Choi S, Hoffman KE, McGuire SE, Chen HC, Wang X, Thaker NG, Bruno T, Henry TG, et al. The Value of Brachytherapy for Intermediate-Risk Localized Prostate Cancer Using Ichom Outcomes and Time-Driven Activity-Based Costing: Results From a Phase 2 Prospective Trial of 300 Patients. International Journal of Radiation Oncology, Biology, Physics. 96: E400-E401. PMID 27674592 DOI: 10.1016/J.Ijrobp.2016.06.1637 |
0.388 |
|
| 2016 |
Choi S, Levy LB, Lee KK, Nguyen QN, Lee AK, McGuire SE, Kudchadker R, Du W, Hoffman KE, Mahmood U, Frank SJ, Kuban DA. Identifying a Subgroup of High-Risk Prostate Cancer Patients With Worse Clinical Outcomes: Should There Be a "Very High-Risk" Group? International Journal of Radiation Oncology, Biology, Physics. 96: E240-E241. PMID 27674151 DOI: 10.1016/J.Ijrobp.2016.06.1228 |
0.371 |
|
| 2016 |
Hoffman KE, Skinner H, Pugh TJ, Voong KR, Levy LB, Choi S, Frank SJ, Lee AK, Mahmood U, McGuire SE, Schlembach PJ, Du W, Johnson J, Kudchadker RJ, Kuban DA. Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial. American Journal of Clinical Oncology. PMID 27635624 DOI: 10.1097/Coc.0000000000000325 |
0.4 |
|
| 2016 |
Christensen LL, True K, Hamilton MP, Nielsen MM, Damas ND, Damgaard CK, Ongen H, Dermitzakis E, Bramsen JB, Pedersen JS, Lund AH, Vang S, Stribolt K, Madsen MR, Laurberg S, ... McGuire SE, et al. SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism. Molecular Oncology. PMID 27396952 DOI: 10.1016/J.Molonc.2016.06.003 |
0.334 |
|
| 2016 |
Hamilton MP, Rajapakshe KI, Bader DA, Cerne JZ, Smith EA, Coarfa C, Hartig SM, McGuire SE. The Landscape of microRNA Targeting in Prostate Cancer Defined by AGO-PAR-CLIP. Neoplasia (New York, N.Y.). 18: 356-70. PMID 27292025 DOI: 10.1016/J.Neo.2016.04.008 |
0.615 |
|
| 2016 |
Kaushik AK, Shojaie A, Panzitt K, Sonavane R, Venghatakrishnan H, Manikkam M, Zaslavsky A, Putluri V, Vasu VT, Zhang Y, Khan AS, Lloyd S, Szafran AT, Dasgupta S, Bader DA, ... ... McGuire SE, et al. Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer. Nature Communications. 7: 11612. PMID 27194471 DOI: 10.1038/Ncomms11612 |
0.667 |
|
| 2016 |
McGuire SE. DNA Damage and Repair Pathway Profiles as Biomarkers in High-Risk Prostate Cancer. Jama Oncology. 2: 480-1. PMID 26747678 DOI: 10.1001/Jamaoncol.2015.4952 |
0.382 |
|
| 2016 |
Holliday EB, Kuban DA, Bolukbasi Y, Levy L, Master P, Choi S, Frank SJ, McGuire SE, Mahmood U, Pugh TJ, Hoffman KE. Outcomes after adjuvant radiation therapy for prostate cancer at a comprehensive cancer center Journal of Radiation Oncology. 5: 287-292. DOI: 10.1007/S13566-016-0248-5 |
0.432 |
|
| 2015 |
Hartig SM, Hamilton MP, Bader DA, McGuire SE. The miRNA Interactome in Metabolic Homeostasis. Trends in Endocrinology and Metabolism: Tem. PMID 26492831 DOI: 10.1016/J.Tem.2015.09.006 |
0.578 |
|
| 2015 |
Hartig SM, Bader DA, Abadie KV, Motamed M, Hamilton MP, Long W, York B, Mueller M, Wagner M, Trauner M, Chan L, Bajaj M, Moore DD, Mancini MA, McGuire SE. Ubc9 Impairs Activation of the Brown Fat Energy Metabolism Program in Human White Adipocytes. Molecular Endocrinology (Baltimore, Md.). 29: 1320-33. PMID 26192107 DOI: 10.1210/Me.2015-1084 |
0.585 |
|
| 2015 |
Chapin BF, Mcguire SE, Wang X, Troncoso P, Davis JW, Navai N, Subudhi SK, Zurita AJ, Araujo JC, Pettaway CA, Matin SF, Pisters LL, Ward JF, Tu S, Wang J, et al. A prospective, multicenter, randomized phase II trial of best systemic therapy (BST) or BST plus definitive treatment (Surgery or Radiation) of the primary tumor in metastatic prostate cancer. Journal of Clinical Oncology. 33: TPS5075-TPS5075. DOI: 10.1200/Jco.2015.33.15_Suppl.Tps5075 |
0.408 |
|
| 2015 |
Holliday E, Kuban D, Levy L, Bolukbasi Y, Master P, Choi S, Pugh T, McGuire S, Mahmood U, Frank S, Hoffman K. Select Men Benefit From Androgen Deprivation Therapy Delivered With Salvage Radiation Therapy After Prostatectomy International Journal of Radiation Oncology*Biology*Physics. 93: S133-S134. DOI: 10.1016/J.Ijrobp.2015.07.318 |
0.324 |
|
| 2015 |
Choi S, Nguyen Q, Pugh T, Mahmood U, McGuire S, Hoffman K, Frank S, Kuban D, Lee A. Results of Scanning Beam Proton Therapy (SCBT) for the Treatment of Patients With High-Risk Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 93: E243-E244. DOI: 10.1016/J.Ijrobp.2015.07.1161 |
0.407 |
|
| 2015 |
Mahmood U, Huo J, Koshy M, Pugh T, McGuire S, Choi S, Frank S, Lee A, Kuban D, Giordano S, Buchholz T, Smith B, Hoffman K. Image Guidance is Associated With Decreased Gastrointestinal Toxicity in Patients Receiving Definitive External Beam Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 93: E242. DOI: 10.1016/J.Ijrobp.2015.07.1156 |
0.415 |
|
| 2014 |
Wang J, Kudchadker R, Choi S, Pettaway CA, Choi H, Hobbs BD, Occena MC, McGuire SE, Pugh TJ, Hoffman K, Mahmood U, Kuban DA. Local recurrence map to guide target volume delineation after radical prostatectomy. Practical Radiation Oncology. 4: e239-46. PMID 25407875 DOI: 10.1016/J.Prro.2014.02.007 |
0.388 |
|
| 2014 |
Coarfa C, Pichot C, Jackson A, Tandon A, Amin V, Raghuraman S, Paithankar S, Lee AV, McGuire SE, Milosavljevic A. Analysis of interactions between the epigenome and structural mutability of the genome using Genboree Workbench tools. Bmc Bioinformatics. 15: S2. PMID 25080362 DOI: 10.1186/1471-2105-15-S7-S2 |
0.306 |
|
| 2014 |
Bian SX, Kuban DA, Levy LB, Oh J, Choi S, McGuire SE, Frank SJ, Mahmood U, Nguyen PL, Pugh TJ, Lee AK, Hoffman KE. The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer. American Journal of Clinical Oncology. PMID 24732810 DOI: 10.1097/COC.0000000000000071 |
0.419 |
|
| 2014 |
Hoffman KE, Voong KR, Pugh TJ, Skinner H, Levy LB, Takiar V, Choi S, Du W, Frank SJ, Johnson J, Kanke J, Kudchadker RJ, Lee AK, Mahmood U, McGuire SE, et al. Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial. International Journal of Radiation Oncology, Biology, Physics. 88: 1074-84. PMID 24661661 DOI: 10.1016/J.Ijrobp.2014.01.015 |
0.362 |
|
| 2014 |
Chapin BF, McGuire SE, Aparicio A. Is treatment of the primary tumor in metastatic prostate cancer justified? European Urology. 65: 1067-8. PMID 24411278 DOI: 10.1016/J.Eururo.2013.12.011 |
0.377 |
|
| 2014 |
Bader DA, Cerne JZ, McGuire SE. Recent Developments in Androgen Deprivation Therapy for Locally Advanced Prostate Cancer Oral History Review. 10: 133. DOI: 10.17925/Ohr.2014.10.2.133 |
0.667 |
|
| 2014 |
Mahmood U, Walker G, Levy L, Pugh T, McGuire S, Choi S, Frank S, Lee A, Kuban D, Hoffman K. Impact of Insurance Status on Treatment Selection for Localized Prostate Cancer in the United States International Journal of Radiation Oncology*Biology*Physics. 90: S582. DOI: 10.1016/J.Ijrobp.2014.05.1752 |
0.396 |
|
| 2013 |
Hamilton MP, Rajapakshe K, Hartig SM, Reva B, McLellan MD, Kandoth C, Ding L, Zack TI, Gunaratne PH, Wheeler DA, Coarfa C, McGuire SE. Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif. Nature Communications. 4: 2730. PMID 24220575 DOI: 10.1038/Ncomms3730 |
0.301 |
|
| 2013 |
Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE, ... McGuire SE, et al. Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 87: 946-53. PMID 24139077 DOI: 10.1016/J.Ijrobp.2013.08.032 |
0.415 |
|
| 2013 |
Cerne JZ, McGuire SE, Grant SR, Munsell MF, Lee AK, Kudchadker RJ, Choi SL, Mahmood U, Hoffman KE, Pugh TJ, Frank SJ, Kuban DA. Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients. Prostate Cancer and Prostatic Diseases. 16: 346-51. PMID 23939133 DOI: 10.1038/Pcan.2013.26 |
0.453 |
|
| 2013 |
Hartig SM, Feng Q, Ochsner SA, Xiao R, McKenna NJ, McGuire SE, He B. Androgen receptor agonism promotes an osteogenic gene program in preadipocytes. Biochemical and Biophysical Research Communications. 434: 357-62. PMID 23567971 DOI: 10.1016/J.Bbrc.2013.03.078 |
0.324 |
|
| 2013 |
Pair ML, Du W, Rojas HD, Kanke JE, McGuire SE, Lee AK, Kuban DA, Kudchadker RJ. Dosimetric effects of weight loss or gain during volumetric modulated arc therapy and intensity-modulated radiation therapy for prostate cancer. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists. 38: 251-4. PMID 23540491 DOI: 10.1016/J.Meddos.2013.02.004 |
0.397 |
|
| 2013 |
McGuire SE, Lee AK, Cerne JZ, Munsell MF, Levy LB, Kudchadker RJ, Choi SL, Nguyen QN, Hoffman KE, Pugh TJ, Frank SJ, Corn PG, Logothetis CJ, Kuban DA. PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era. International Journal of Radiation Oncology, Biology, Physics. 85: e39-46. PMID 23102837 DOI: 10.1016/J.Ijrobp.2012.08.036 |
0.44 |
|
| 2013 |
Castle KO, Hoffman KE, Levy LB, Lee AK, Choi S, Nguyen QN, Frank SJ, Pugh TJ, McGuire SE, Kuban DA. Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era? International Journal of Radiation Oncology, Biology, Physics. 85: 693-9. PMID 22836052 DOI: 10.1016/J.Ijrobp.2012.06.030 |
0.365 |
|
| 2013 |
Pugh TJ, Frank SJ, Achim M, Kuban DA, Lee AK, Hoffman KE, McGuire SE, Swanson DA, Kudchadker R, Davis JW. Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy. Brachytherapy. 12: 204-9. PMID 22673704 DOI: 10.1016/J.Brachy.2011.12.013 |
0.39 |
|
| 2013 |
Choi S, Nguyen Q, Pugh T, Frank S, Hoffman K, McGuire S, Mahmood U, Kuban D, Lee A. Proton Therapy for Prostate Cancer Does Not Affect Testosterone Level After Treatment International Journal of Radiation Oncology*Biology*Physics. 87: S387-S388. DOI: 10.1016/J.Ijrobp.2013.06.1016 |
0.433 |
|
| 2013 |
McGuire S, Cerne J, Grant S, Munsell M, Lee A, Choi S, Pugh T, Frank S, Hoffman K, Kuban D. The Association of Patient, Tumor, and Treatment Characteristics With Biochemical Response to Neoadjuvant Androgen Deprivation Therapy in Prostate Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 87: S384. DOI: 10.1016/J.Ijrobp.2013.06.1007 |
0.385 |
|
| 2012 |
Bian S, Kuban DA, Levy LB, Oh JH, Castle K, Pugh T, Choi S, McGuire SE, Frank SJ, Nguyen PL, Lee A, Hoffman KE. Effect of adding short-term androgen deprivation therapy to dose-escalated radiation therapy on failure-free survival for select men with intermediate-risk prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 176. PMID 27968096 DOI: 10.1200/Jco.2012.30.5_Suppl.176 |
0.405 |
|
| 2012 |
Sharp HJ, Swanson DA, Pugh TJ, Zhang M, Phan J, Kudchadker R, Bruno TL, Kuban DA, Lee AK, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Frank SJ. Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy. Practical Radiation Oncology. 2: e7-e13. PMID 24674130 DOI: 10.1016/J.Prro.2011.11.010 |
0.348 |
|
| 2012 |
Bian SX, Kuban DA, Levy LB, Oh J, Castle KO, Pugh TJ, Choi S, McGuire SE, Nguyen QN, Frank SJ, Nguyen PL, Lee AK, Hoffman KE. Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 23: 2346-52. PMID 22357249 DOI: 10.1093/Annonc/Mds001 |
0.409 |
|
| 2012 |
Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease? European Journal of Cancer (Oxford, England : 1990). 48: 1664-71. PMID 22336663 DOI: 10.1016/J.Ejca.2012.01.026 |
0.398 |
|
| 2012 |
Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Improvement in prostate cancer survival over time: a 20-year analysis. Cancer Journal (Sudbury, Mass.). 18: 1-8. PMID 22290249 DOI: 10.1097/Ppo.0B013E3182467419 |
0.461 |
|
| 2012 |
Lee A, Choi S, Nguyen Q, Pugh T, Mathai B, Frank S, Hoffman K, Kuban D, McGuire S, Munsell M. Patient Quality of Life After Proton Therapy (1.8 vs 2 Gray Equivalents) for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S366-S367. DOI: 10.1016/J.Ijrobp.2012.07.967 |
0.409 |
|
| 2012 |
Skinner H, Hoffman K, Levy L, Lee A, Frank S, Choi S, McGuire S, Pugh T, Kuban D. Toxicity and Dosimetric Parameters Related to Conventional Versus Dose-Escalated, Hypofractionated Radiation in Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S147. DOI: 10.1016/J.Ijrobp.2012.07.379 |
0.398 |
|
| 2012 |
Choi S, Umfleet W, Palmer M, Nguyen Q, McGuire S, Pugh T, Kuban D, Lee A. Comparison of Scanning Beam Proton Therapy (SBPT) to Intensity Modulated X-ray Therapy (IMRT) for Postoperative Salvage Treatment of Prostate Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 84: S843-S844. DOI: 10.1016/J.Ijrobp.2012.07.2258 |
0.38 |
|
| 2012 |
Frank S, Pugh T, Munsell M, Kudchadker R, Bruno T, Kuban D, Lee A, Choi S, McGuire S, Swanson D. Prostate Brachytherapy Long-term Outcomes, Quality of Life, and Patient-reported Satisfaction International Journal of Radiation Oncology*Biology*Physics. 84: S392-S393. DOI: 10.1016/J.Ijrobp.2012.07.1035 |
0.324 |
|
| 2012 |
Pugh T, Choi S, Nguyen Q, De Gracia B, Munsell M, Frank S, Kuban D, Hoffman K, McGuire S, Lee A. Prospective Quality of Life and Toxicity Between Passively Scattered and Spot-Scanning Proton Therapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S384. DOI: 10.1016/J.Ijrobp.2012.07.1012 |
0.335 |
|
| 2011 |
Kim MM, Hoffman KE, Levy LB, Frank SJ, Choi S, Nguyen QN, Pugh T, McGuire SE, Lee A, Kuban DA. Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 181. PMID 27968478 DOI: 10.1200/Jco.2011.29.7_Suppl.181 |
0.436 |
|
| 2011 |
Pugh T, Frank S, Achim M, Kuban D, Lee A, Choi S, Nguyen Q, Hoffman K, McGuire S, Swanson D. Prediction of Extraprostatic Extension in Intermediate Risk Prostate Cancer: The Evolving Role of Endorectal MRI International Journal of Radiation Oncology*Biology*Physics. 81: S398. DOI: 10.1016/J.Ijrobp.2011.06.642 |
0.41 |
|
| 2010 |
Kim M, Hoffman K, Levy L, Master P, Frank S, Choi S, Nguyen Q, Mcguire S, Lee A, Kuban D. Improvement in Prostate Cancer Outcomes Over Time: A Twenty-Year Analysis International Journal of Radiation Oncology*Biology*Physics. 78: S191-S192. DOI: 10.1016/J.Ijrobp.2010.07.466 |
0.41 |
|
| 2010 |
Nguyen Q, Levy L, Lee A, Choi S, Frank S, Hoffman K, McGuire S, Kuban D. Risk Factors Predicting Failure and Prostate Cancer Mortality in High Risk Prostate Cancer Patients Treated with Definitive External Beam Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 78: S125. DOI: 10.1016/J.Ijrobp.2010.07.315 |
0.43 |
|
| 2010 |
McGuire S, Levy L, Settle S, Choi S, Nguyen Q, Hoffman K, Frank S, Lee A, Kuban D. PSA Response to Neoadjuvant Androgen Suppression Therapy Prior to High Dose Radiotherapy Predicts Survival in Clinically Localized High Risk Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 78: S124-S125. DOI: 10.1016/J.Ijrobp.2010.07.314 |
0.437 |
|
| 2010 |
Kuban D, Nogueras-Gonzalez G, Hamblin L, Lee A, Choi S, Frank S, Nguyen Q, Hoffman K, McGuire S, Munsell M. Preliminary Report of a Randomized Dose Escalation Trial for Prostate Cancer using Hypofractionation International Journal of Radiation Oncology*Biology*Physics. 78: S58-S59. DOI: 10.1016/J.Ijrobp.2010.07.170 |
0.404 |
|
| 2009 |
Hartmaier RJ, Tchatchou S, Richter AS, Wang J, McGuire SE, Skaar TC, Rae JM, Hemminki K, Sutter C, Ditsch N, Bugert P, Weber BH, Niederacher D, Arnold N, Varon-Mateeva R, et al. Nuclear receptor coregulator SNP discovery and impact on breast cancer risk. Bmc Cancer. 9: 438. PMID 20003447 DOI: 10.1186/1471-2407-9-438 |
0.312 |
|
| 2007 |
McGuire SE, Gonzalez-Angulo AM, Huang EH, Tucker SL, Kau SW, Yu TK, Strom EA, Oh JL, Woodward WA, Tereffe W, Hunt KK, Kuerer HM, Sahin AA, Hortobagyi GN, Buchholz TA. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. International Journal of Radiation Oncology, Biology, Physics. 68: 1004-9. PMID 17418973 DOI: 10.1016/J.Ijrobp.2007.01.023 |
0.312 |
|
| 2006 |
McGuire SE, Deshazer M, Davis RL. Corrigendum to “Thirty years of olfactory learning and memory research in Drosophila melanogaster” [Progress in Neurobiology 76 (2005) 328–347] Progress in Neurobiology. 79: 341-342. DOI: 10.1016/J.Pneurobio.2006.03.005 |
0.414 |
|
| 2005 |
McGuire SE, Deshazer M, Davis RL. Thirty years of olfactory learning and memory research in Drosophila melanogaster. Progress in Neurobiology. 76: 328-47. PMID 16266778 DOI: 10.1016/J.Pneurobio.2005.09.003 |
0.428 |
|
| 2005 |
McGuire S, Gonzalez-Angulo A, Tucker S, Rouzier R, Strom E, Perkins G, Oh J, Huang E, Sahin A, Hunt K, Hortobagyi G, Buchholz T. Radiation is an Important Component of Therapy for Patients with Stage III Breast Cancer Who Achieve a Pathological Complete Response after Neoadjuvant Chemotherapy International Journal of Radiation Oncology*Biology*Physics. 63: S52. DOI: 10.1016/J.Ijrobp.2005.07.091 |
0.311 |
|
| 2004 |
McGuire SE, Roman G, Davis RL. Gene expression systems in Drosophila: a synthesis of time and space. Trends in Genetics : Tig. 20: 384-91. PMID 15262411 DOI: 10.1016/J.Tig.2004.06.012 |
0.565 |
|
| 2004 |
McGuire SE, Mao Z, Davis RL. Spatiotemporal gene expression targeting with the TARGET and gene-switch systems in Drosophila. Science's Stke : Signal Transduction Knowledge Environment. 2004: pl6. PMID 14970377 DOI: 10.1126/Stke.2202004Pl6 |
0.463 |
|
| 2003 |
McGuire SE, Le PT, Osborn AJ, Matsumoto K, Davis RL. Spatiotemporal rescue of memory dysfunction in Drosophila. Science (New York, N.Y.). 302: 1765-8. PMID 14657498 DOI: 10.1126/Science.1089035 |
0.444 |
|
| 2001 |
McGuire SE, Davis RL. Presenilin-1 and memories of the forebrain. Neuron. 32: 763-5. PMID 11738022 DOI: 10.1016/S0896-6273(01)00525-6 |
0.421 |
|
| 2001 |
McGuire SE, Le PT, Davis RL. The role of Drosophila mushroom body signaling in olfactory memory. Science (New York, N.Y.). 293: 1330-3. PMID 11397912 DOI: 10.1126/Science.1062622 |
0.419 |
|
| 1996 |
Yee D, McGuire SE, Brünner N, Kozelsky TW, Allred DC, Chen SH, Woo SLC. Adenovirus-Mediated Gene Transfer of Herpes Simplex Virus Thymidine Kinase in an Ascites Model of Human Breast Cancer Human Gene Therapy. 7: 1251-1257. PMID 8793549 DOI: 10.1089/Hum.1996.7.10-1251 |
0.307 |
|
| Show low-probability matches. |
